Camu-Camu Reduces Obesity and Improves Diabetic Profiles of Obese and Diabetic Mice: A Dose-Ranging Study.

Abot, Anne; Brochot, Amandine; Pomié, Nicolas; Wemelle, Eve; Druart, Céline; Régnier, Marion; Delzenne, Nathalie M; de Vos, Willem M; Knauf, Claude; Cani, Patrice D

Abot, Anne; Brochot, Amandine; Pomié, Nicolas; Wemelle, Eve; Druart, Céline; Régnier, Marion; Delzenne, Nathalie M; de Vos, Willem M; Knauf, Claude; Cani, Patrice D.

Affiliation

Abot A; Enterosys SAS, 31670 Labège, France.
Brochot A; A-Mansia Biotech SA, The Akkermansia Company, 1435 Mont-Saint-Guibert, Belgium.
Pomié N; Enterosys SAS, 31670 Labège, France.
Wemelle E; Institut National de la Santé et de la Recherche Médicale (INSERM), U1220, Institut de Recherche en Santé Digestive et Nutrition (IRSD), Université Paul Sabatier (UPS), 31000 Toulouse, France.
Druart C; NeuroMicrobiota Lab, International Research Program (IRP) INSERM, 31000 Toulouse, France.
Régnier M; A-Mansia Biotech SA, The Akkermansia Company, 1435 Mont-Saint-Guibert, Belgium.
Delzenne NM; WELBIO-Walloon Excellence in Life Sciences and BIOtechnology, Metabolism and Nutrition Research Group, Louvain Drug Research Institute, Université Catholique de Louvain (UCLouvain), 1200 Brussels, Belgium.
de Vos WM; WELBIO-Walloon Excellence in Life Sciences and BIOtechnology, Metabolism and Nutrition Research Group, Louvain Drug Research Institute, Université Catholique de Louvain (UCLouvain), 1200 Brussels, Belgium.
Knauf C; Laboratory of Microbiology, Wageningen University, 6708 WE Wageningen, The Netherlands.
Cani PD; Human Microbiome Research Program, Faculty of Medicine, University of Helsinki, 00014 Helsinki, Finland.